share_log

Allogene Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-David Chang, M.D., Ph.D.(5.8%),Chang 2006 Family Trust(0.7%), etc.

SEC announcement ·  Feb 14 16:39
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more